Skip to main content

Table 1 Clinicopathological characteristics of patients

From: The ability of anexelekto (AXL) expression and TERT promoter mutation to predict radioiodine-refractory differentiated thyroid carcinoma

Variable

Total N (%)

Age (years)

Mean ± SD

47.860 ± 14.436

≥ 40

60 (74.1)

< 40

21 (25.9)

Sex

Male

21 (25.9)

Female

60 (74.1)

Histological type

Follicular-derived carcinomas, high-grade

8 (9.9)

FTC

4 (4.9)

PTC

63 (77.8)

IEFVP

6 (7.4)

Aggressive subtype

Aggressive

16 (19.8)

Nonaggressive

65 (80.2)

TNM Staging

II-IV

20 (24.7)

I

61 (75.3)

LVI

Yes

47 (58.1)

No

34 (41.9)

m-ETE

Yes

43 (53.1)

No

38 (46.9)

AXL expression

> 10% (high)

51 (63)

0–10% (negative/low)

30 (37)

TERT promoter

Mutation

23 (28.4)

Wild-type

58 (71.6)

  1. SD, standard deviation; FTC, follicular thyroid carcinoma; PTC, papillary thyroid carcinoma; IEFVP, invasive encapsulated follicular variant of papillary thyroid carcinoma; LVI, lymphovascular invasion; m-ETE, microscopic extrathyroid extension; AXL, anexelekto; TERT, telomerase reverse transcriptase